Stroke, Vol 25, 2153-2158, Copyright © 1994 by American Heart Association
N Venketasubramanian, I Prohovnik, A Hurlet, JP Mohr and S Piomelli
BACKGROUND AND PURPOSE: Sickle cell disease is associated with cerebral
hyperemia, which is therapeutically reduced by transfusion; however, the
process of transfusion-induced cerebral perfusion changes has heretofore
not been observed. METHODS: We document the acute changes of intracranial
arterial velocity in 10 patients (7 with strokes, 3 without) undergoing
transfusion therapy using transcranial Doppler ultrasonography. Middle
cerebral artery velocities were bilaterally measured every 30 minutes for
the duration of transfusion (4 to 5 hours). Regional cerebral blood flow
was quantified in 5 of these patients before the transfusion and 24 hours
later by the 133Xe technique. RESULTS: Velocities in stroke-associated
vessels (64.33 +/- 18.65 cm/s; n = 6) were significantly lower than in
uninfarcted territories (99.54 +/- 27.39 cm/s; n = 13), and both types of
vessels showed a robust reduction of blood flow velocities during
transfusion. The rates of reduction were not significantly different as a
function of prior stroke but did correlate with pretransfusion velocities
and with the rise in hematocrit (multiple r = .887, P < .001). These
reductions occurred rapidly within the first 3 hours of transfusion.
Velocities attained at the end of transfusion were maintained in the hour
after transfusion and the next day. CONCLUSIONS: We conclude that
transfusion induces rapid changes in cerebral hemodynamics that are related
to pretransfusion velocities and a rise in hematocrit. Transcranial Doppler
provides a safe, simple, and noninvasive technique of monitoring these
changes and may provide a means of making therapeutic decisions regarding
transfusion therapy in patients with sickle cell anemia.
ARTICLES
Middle cerebral artery velocity changes during transfusion in sickle cell anemia
Department of Neurology, Columbia-Presbyterian Medical Center, New York, NY.
This article has been cited by other articles:
![]() |
S. A. Zimmerman, W. H. Schultz, S. Burgett, N. A. Mortier, and R. E. Ware Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia Blood, August 1, 2007; 110(3): 1043 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Lee, S. Piomelli, S. Granger, S. T. Miller, S. Harkness, D. J. Brambilla, R. J. Adams, and for the STOP Study Investigators Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results Blood, August 1, 2006; 108(3): 847 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Powars Childhood stroke frequency decreased in California during 1999 and 2000 Blood, July 15, 2004; 104(2): 298 - 299. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |